BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chouraqui E, Leguilloux L, Dohan A, Gouya H, Barral M, Vallet-Pichard A, Sogni P, Pol S, Mallet V, Soyer P. Can we differentiate HIV-associated obliterative portopathy from liver cirrhosis using MRI? Eur Radiol 2020;30:213-23. [PMID: 31410601 DOI: 10.1007/s00330-019-06391-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Panvini N, Dioguardi Burgio M, Sartoris R, Maino C, Van Wettere M, Plessier A, Payence A, Rautou PE, Ladouceur M, Vilgrain V, Ronot M. MR imaging features and long-term evolution of benign focal liver lesions in Budd-Chiari syndrome and Fontan-associated liver disease. Diagn Interv Imaging 2021:S2211-5684(21)00198-4. [PMID: 34654671 DOI: 10.1016/j.diii.2021.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Kang JH, Kim DH, Kim SY, Kang HJ, Lee JB, Kim KW, Lee SS, Choi J, Lim YS. Porto-sinusoidal vascular disease with portal hypertension versus liver cirrhosis: differences in imaging features on CT and hepatobiliary contrast-enhanced MRI. Abdom Radiol (NY) 2021;46:1891-903. [PMID: 33095310 DOI: 10.1007/s00261-020-02831-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
3 . HIV-assoziierte obliterative Pfortadervenopathie in der MRT. Rofo 2020;193:15-15. [DOI: 10.1055/a-1151-9118] [Reference Citation Analysis]
4 El Homsi M, Isabel Fiel M, Taouli B. Hepatocellular carcinoma in obliterative portal venopathy. Diagn Interv Imaging 2021;102:115-6. [PMID: 33189587 DOI: 10.1016/j.diii.2020.10.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]